The global oxygen therapy equipment market is witnessing substantial growth, fueled by the rising prevalence of respiratory disorders, increasing use in critical care settings, and rapid technological advancements. The growing incidence of chronic lung diseases such as COPD and asthma has heightened

The food allergy market is projected to experience significant growth in the coming years, driven by the adoption of recently approved therapies and promising emerging treatments such as Viaskin (DBV712) Peanut Patch (DBV Technologies), PVX108 (Aravax), Remibrutinib (Novartis), SLIT tablet (ALK-Abello), RPT904

The choroidal neovascularization therapeutics market is anticipated to grow further, driven by key factors such as the increasing prevalence of the condition, technological advancements, and emerging therapies—including AbbVie and REGENXBIO’s ABBV-RGX-314, Adverum Biotechnologies’ Ixoberogene soroparvovec, Neuracle Genetics’ NG101, and others—over the forecast